1-2303939-C-T

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_003036.4(SKI):​c.1311C>T​(p.Ala437Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0102 in 1,611,696 control chromosomes in the GnomAD database, including 98 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A437A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0078 ( 10 hom., cov: 32)
Exomes 𝑓: 0.010 ( 88 hom. )

Consequence

SKI
NM_003036.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -2.64
Variant links:
Genes affected
SKI (HGNC:10896): (SKI proto-oncogene) This gene encodes the nuclear protooncogene protein homolog of avian sarcoma viral (v-ski) oncogene. It functions as a repressor of TGF-beta signaling, and may play a role in neural tube development and muscle differentiation. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 1-2303939-C-T is Benign according to our data. Variant chr1-2303939-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 139114.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-2303939-C-T is described in Lovd as [Benign]. Variant chr1-2303939-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-2.64 with no splicing effect.
BS2
High AC in GnomAd4 at 1182 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SKINM_003036.4 linkc.1311C>T p.Ala437Ala synonymous_variant Exon 4 of 7 ENST00000378536.5 NP_003027.1 P12755

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SKIENST00000378536.5 linkc.1311C>T p.Ala437Ala synonymous_variant Exon 4 of 7 1 NM_003036.4 ENSP00000367797.4 P12755
SKIENST00000507179.1 linkn.294C>T non_coding_transcript_exon_variant Exon 1 of 2 2
SKIENST00000704337.1 linkn.*31C>T downstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.00776
AC:
1181
AN:
152188
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00661
Gnomad ASJ
AF:
0.0225
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00724
Gnomad FIN
AF:
0.0162
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00998
Gnomad OTH
AF:
0.00956
GnomAD3 exomes
AF:
0.00784
AC:
1883
AN:
240128
Hom.:
18
AF XY:
0.00781
AC XY:
1031
AN XY:
132056
show subpopulations
Gnomad AFR exome
AF:
0.00155
Gnomad AMR exome
AF:
0.00384
Gnomad ASJ exome
AF:
0.0218
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00405
Gnomad FIN exome
AF:
0.0182
Gnomad NFE exome
AF:
0.00896
Gnomad OTH exome
AF:
0.00945
GnomAD4 exome
AF:
0.0104
AC:
15243
AN:
1459390
Hom.:
88
Cov.:
32
AF XY:
0.0101
AC XY:
7342
AN XY:
726018
show subpopulations
Gnomad4 AFR exome
AF:
0.00176
Gnomad4 AMR exome
AF:
0.00433
Gnomad4 ASJ exome
AF:
0.0215
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00364
Gnomad4 FIN exome
AF:
0.0171
Gnomad4 NFE exome
AF:
0.0114
Gnomad4 OTH exome
AF:
0.00955
GnomAD4 genome
AF:
0.00776
AC:
1182
AN:
152306
Hom.:
10
Cov.:
32
AF XY:
0.00782
AC XY:
582
AN XY:
74468
show subpopulations
Gnomad4 AFR
AF:
0.00224
Gnomad4 AMR
AF:
0.00660
Gnomad4 ASJ
AF:
0.0225
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00725
Gnomad4 FIN
AF:
0.0162
Gnomad4 NFE
AF:
0.0100
Gnomad4 OTH
AF:
0.00946
Alfa
AF:
0.00568
Hom.:
0
Bravo
AF:
0.00696
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.0115
EpiControl
AF:
0.00855

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 27, 2014
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Oct 14, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SKI: BP4, BP7, BS1, BS2 -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Shprintzen-Goldberg syndrome Benign:3
Jul 22, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 27, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Feb 06, 2015
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
1.9
DANN
Benign
0.67
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140889128; hg19: chr1-2235378; API